When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: HBO Well, that was ...

Netflix's new show The Abandons has a true cliffhanger ending, and we're here to break it down. One of the love stories of the season does get a (kind of) resolution. Did [SPOILER] and [SPOILER] ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

IT: Welcome to Derry Episode 5 ends with a development that should send chills down any hardcore Stephen King fan’s spine. It’s not enough that our heroes finally visited the house on Neibolt Street ...

SPOILER ALERT: This story contains spoilers for the first two episodes of “Pluribus,” streaming now on Apple TV. Not only did “Breaking Bad” earn four more seasons that cemented it as one of the ...

The moves to fire or sideline generals and admirals are without precedent in recent decades and have rattled the top brass. Credit...Photographs by Andrew Caballero-Reynolds/Agence France-Presse — ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Aaron covers what's exciting and new in the world of home entertainment and streaming TV. Previously, he wrote about entertainment for places like Rotten Tomatoes, Inverse, TheWrap and The Hollywood ...